Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

NCT04832399 · clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen